India · Delayed Price · Currency is INR NSE:INDRAMEDCO Statistics
Total Valuation
NSE:INDRAMEDCO has a market cap or net worth of INR 34.66 billion. The enterprise value is 30.36 billion.
| Market Cap | 34.66B |
| Enterprise Value | 30.36B |
Important Dates
The next estimated earnings date is Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 91.67M |
| Shares Outstanding | 91.67M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 5.05% |
| Float | 40.99M |
Valuation Ratios
The trailing PE ratio is 19.84 and the forward PE ratio is 19.08.
| PE Ratio | 19.84 |
| Forward PE | 19.08 |
| PS Ratio | 2.47 |
| PB Ratio | 5.26 |
| P/TBV Ratio | 5.27 |
| P/FCF Ratio | 24.24 |
| P/OCF Ratio | 20.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.77, with an EV/FCF ratio of 21.23.
| EV / Earnings | 17.37 |
| EV / Sales | 2.16 |
| EV / EBITDA | 11.77 |
| EV / EBIT | 14.10 |
| EV / FCF | 21.23 |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.67 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.22 |
| Interest Coverage | 74.25 |
Financial Efficiency
Return on equity (ROE) is 29.55% and return on invested capital (ROIC) is 21.59%.
| Return on Equity (ROE) | 29.55% |
| Return on Assets (ROA) | 15.29% |
| Return on Invested Capital (ROIC) | 21.59% |
| Return on Capital Employed (ROCE) | 29.44% |
| Revenue Per Employee | 4.63M |
| Profits Per Employee | 575,750 |
| Employee Count | 3,035 |
| Asset Turnover | 1.60 |
| Inventory Turnover | 72.26 |
Taxes
In the past 12 months, NSE:INDRAMEDCO has paid 596.80 million in taxes.
| Income Tax | 596.80M |
| Effective Tax Rate | 25.46% |
Stock Price Statistics
The stock price has decreased by -21.11% in the last 52 weeks. The beta is 0.70, so NSE:INDRAMEDCO's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -21.11% |
| 50-Day Moving Average | 468.03 |
| 200-Day Moving Average | 465.73 |
| Relative Strength Index (RSI) | 19.14 |
| Average Volume (20 Days) | 165,725 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:INDRAMEDCO had revenue of INR 14.05 billion and earned 1.75 billion in profits. Earnings per share was 19.06.
| Revenue | 14.05B |
| Gross Profit | 8.48B |
| Operating Income | 2.15B |
| Pretax Income | 2.34B |
| Net Income | 1.75B |
| EBITDA | 2.54B |
| EBIT | 2.15B |
| Earnings Per Share (EPS) | 19.06 |
Balance Sheet
The company has 4.61 billion in cash and 313.40 million in debt, with a net cash position of 4.30 billion or 46.92 per share.
| Cash & Cash Equivalents | 4.61B |
| Total Debt | 313.40M |
| Net Cash | 4.30B |
| Net Cash Per Share | 46.92 |
| Equity (Book Value) | 6.58B |
| Book Value Per Share | 71.88 |
| Working Capital | 3.71B |
Cash Flow
In the last 12 months, operating cash flow was 1.72 billion and capital expenditures -287.70 million, giving a free cash flow of 1.43 billion.
| Operating Cash Flow | 1.72B |
| Capital Expenditures | -287.70M |
| Free Cash Flow | 1.43B |
| FCF Per Share | 15.60 |
Margins
Gross margin is 60.37%, with operating and profit margins of 15.33% and 12.44%.
| Gross Margin | 60.37% |
| Operating Margin | 15.33% |
| Pretax Margin | 16.69% |
| Profit Margin | 12.44% |
| EBITDA Margin | 18.10% |
| EBIT Margin | 15.33% |
| FCF Margin | 10.18% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 1.19%.
| Dividend Per Share | 4.50 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 24.92% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 5.04% |
| FCF Yield | 4.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |